CLASS II ONGOING Device recall · Reported 28 Sep 2022 · FDA Enforcement Report

Beq-hls 5050 Usa recalled by Maquet Medical Systems U

Maquet Medical Systems USA is recalling Beq-hls 5050 Usa, distributed nationwide in the US. The recall was initiated on 22 Jul 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 04037691773513 Lot 3000183908
Quantity recalled206 US; 48,960 Worldwide

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1765-2022
FDA event ID
90740
Recalling firm
Maquet Medical Systems USA, Wayne, NJ
Classification
Class II
Status
Ongoing
Recall initiated
22 Jul 2022
FDA classified
19 Sep 2022
Reported
28 Sep 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

22 Jul 2022Recall initiated by company
19 Sep 2022Classified by FDA+59 days
28 Sep 2022Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm has expanded the recall for the HLS Set Advanced regarding a potential breach in the sterility barrier that may result in compromised product sterility (prior recall was initiated November 6, 2020).

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

BEQ-HLS 5050 USA; HLS Set Advanced 5.0 Part No. 70105.2797. A preconnected set used for extracorporeal respiratory and/or cardiovascular support, as part of the CARDIOHELP System.

Where it was distributed

Worldwide distribution - US Nationwide and the countries Canada and Australia.

Nationwide

Questions about this recall

Why was it recalled?

The firm has expanded the recall for the HLS Set Advanced regarding a potential breach in the sterility barrier that may result in compromised product sterility (prior recall was initiated November 6, 2020).

Which lots are affected?

UDI-DI: 04037691773513 Lot 3000183908

Where was it sold?

Worldwide distribution - US Nationwide and the countries Canada and Australia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 90740

More recalls from Maquet Medical Systems USA

All 41

Other CPAP & Ventilators recalls

All 552